Nephrotic Syndrome antibodies

and ELISA kits, proteins related to Nephrotic Syndrome.

Introduction to Nephrotic Syndrome

Nephrotic Syndrome is a kidney disorder characterized by excessive loss of protein in the urine, low levels of protein in the blood, swelling, and elevated cholesterol levels. This condition occurs when the glomeruli—the tiny filtering units within the kidneys—become damaged, allowing proteins such as albumin to leak into the urine. Nephrotic Syndrome can result from various underlying diseases, including diabetes, lupus, and certain infections. Patients often experience significant fluid retention, leading to swelling in the legs, ankles, and around the eyes. Current research is increasingly focused on the role of antibodies and the immune system in the development and progression of Nephrotic Syndrome. By targeting specific antibodies, scientists aim to create more effective treatments that can reduce proteinuria, preserve kidney function, and enhance the quality of life for those affected by this challenging condition.

Nephrotic Syndrome biomarkers

M00199-1

Anti-Wilms Tumor Protein WT1 Rabbit Monoclonal Antibody, Construction of db/db model to evaluate changes in renal pathology lipid metabolism. Two groups of twenty...

A01756-2

Anti-CD2AP Antibody Picoband®, IF analysis of CD2AP using anti-CD2AP antibody (A01756-2).
CD2AP was detected in an immunocytochemical section of Hela cells. Enzyme anti...

A03154-1

Anti-Synaptopodin/SYNPO Antibody Picoband®, IF analysis of Synaptopodin/SYNPO using anti-Synaptopodin/SYNPO antibody (A03154-1).
Synaptopodin/SYNPO was det...

Protein Name	Gene Name	Function
Nephrin	NPHS1	Maintains podocyte slit diaphragm structure
Podocin	NPHS2	Stabilizes slit diaphragm and podocyte architecture
WT1	WT1	Transcription factor essential for podocyte development
TRPC6	TRPC6	Calcium channel involved in podocyte injury and proteinuria
CD2AP	CD2AP	Adaptor protein involved in slit diaphragm signaling
LMX1B	LMX1B	Regulates podocyte gene expression and structure
ACTN4	ACTN4	Actin-binding protein crucial for podocyte cytoskeleton
Synaptopodin	SYNPO	Essential for podocyte actin cytoskeleton integrity
INF2	INF2	Regulates actin dynamics in podocytes
ARHGDIA	ARHGDIA	Modulates Rho GTPase signaling affecting cytoskeleton
VEGFA	VEGFA	Vascular endothelial growth factor involved in glomerular filtration barrier
PLA2R1	PLA2R1	Autoantibody target in idiopathic membranous nephropathy
C3	C3	Complement component involved in immune-mediated glomerular damage
TNF	TNF	Pro-inflammatory cytokine involved in kidney inflammation
IL6	IL6	Pro-inflammatory cytokine implicated in nephrotic pathogenesis
CD80	CD80	Co-stimulatory molecule involved in podocyte injury
MMP9	MMP9	Enzyme involved in extracellular matrix remodeling in kidney
Apolipoprotein A1	APOA1	Lipid transporter affected in nephrotic syndrome
Apolipoprotein B	APOB	Lipid transporter elevated in nephrotic syndrome
Fibrinogen	FGB	Coagulation factor elevated due to nephrotic state

Important Mechanisms

Podocyte Dysfunction

Podocytes, specialized epithelial cells in the glomeruli of the kidneys, play a crucial role in maintaining the filtration barrier that prevents protein loss into the urine. Dysfunction or injury to podocytes is a central mechanism in the pathogenesis of Nephrotic Syndrome. Research in this area focuses on understanding the molecular and cellular alterations that lead to podocyte effacement, detachment, and apoptosis. Key factors include alterations in the actin cytoskeleton, expression of slit diaphragm proteins, and responses to inflammatory cytokines. Genetic mutations affecting podocyte proteins, such as nephrin and podocin, have been linked to hereditary forms of Nephrotic Syndrome. Additionally, studies are investigating the regenerative capacity of podocytes and potential therapeutic targets to restore podocyte function and prevent progression to chronic kidney disease. This sub area is critical for developing targeted therapies that can protect podocytes, maintain the integrity of the glomerular filtration barrier, and ultimately improve patient outcomes in Nephrotic Syndrome.

Immune System Dysregulation

The immune system plays a significant role in the development and progression of Nephrotic Syndrome, particularly in forms such as minimal change disease and focal segmental glomerulosclerosis, which are often responsive to immunosuppressive therapies. Research in immune system dysregulation explores the underlying immunological abnormalities that lead to increased permeability of the glomerular filtration barrier. This includes studies on T-cell dysfunction, abnormal cytokine profiles, and the role of B-cells and autoantibodies. Understanding how immune-mediated mechanisms cause podocyte injury and proteinuria is essential for identifying specific immune targets for intervention. Additionally, this sub area examines the impact of systemic inflammatory conditions on kidney function and the interplay between genetic predispositions and environmental triggers in immune dysregulation. Advancements in this field aim to refine immunomodulatory treatments, reduce reliance on corticosteroids, and minimize side effects by developing more precise therapies tailored to individual immune profiles in patients with Nephrotic Syndrome.